Robert Iannone

Insider Reports History

Entity
Individual
Location
300 The American Way, Morris Plains, NJ
Signature
By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Iannone:

Insider Reports Filed by Robert Iannone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JAZZ Jazz Pharmaceuticals plc Jan 17, 2025 2 -$267K 4 Jan 22, 2025 EVP, G R&D and CMO
ITOS iTeos Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
JAZZ Jazz Pharmaceuticals plc Mar 5, 2024 1 -$505K 4 Mar 7, 2024 EVP, Global Head of R&D
JAZZ Jazz Pharmaceuticals plc Mar 1, 2024 1 $0 4 Mar 5, 2024 EVP, Global Head of R&D
JAZZ Jazz Pharmaceuticals plc Jan 17, 2024 2 -$206K 4 Jan 19, 2024 EVP, Global Head of R&D
ITOS iTeos Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
JAZZ Jazz Pharmaceuticals plc Jun 5, 2023 1 -$170K 4 Jun 7, 2023 EVP, Global Head of Research a
JNCE Jounce Therapeutics, Inc. May 3, 2023 4 $0 4 May 4, 2023 Director
JAZZ Jazz Pharmaceuticals plc Mar 3, 2023 2 -$325K 4 Mar 7, 2023 EVP, Global Head of Research a
JAZZ Jazz Pharmaceuticals plc Dec 9, 2022 1 -$279K 4 Dec 13, 2022 EVP, Global Head of R&D
JNCE Jounce Therapeutics, Inc. Jun 24, 2022 1 $0 4 Jun 28, 2022 Director
ITOS iTeos Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
JAZZ Jazz Pharmaceuticals plc Jun 6, 2022 1 -$193K 4 Jun 8, 2022 EVP, Global Head of R&D
JAZZ Jazz Pharmaceuticals plc Mar 3, 2022 2 -$204K 4 Mar 9, 2022 EVP, Global Head of R&D and Ch
JNCE Jounce Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
ITOS iTeos Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
JAZZ Jazz Pharmaceuticals plc Jun 5, 2021 1 -$213K 4 Jun 9, 2021 EVP R&D, Chief Medical Officer